Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.21.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Cash Flows From Operating Activities    
Net loss $ (7,653) $ (12,074)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 2,943 2,708
Interest accretion expense 270 276
Bad debt (recovery) expense (140) 250
Mark to market on warrants 209 (49)
Stock-based compensation 777 818
Amortization of deferred financing fees 88
Accrued interest 220
ESPP expense 60
Change in fair value of contingent consideration (57)
Gain on DiamiR transaction (235)
Other gains and expenses, net (2)
Other changes in operating assets and liabilities:    
Decrease in accounts receivable 841 2,849
Increase in other current assets (548) (788)
Decrease in accounts payable (2,032) (1,361)
Decrease in accrued salaries and bonus (719) (94)
(Decrease) increase in accrued liabilities (802) 759
(Decrease) increase in long-term liabilities (45) 33
Net cash used in operating activities (6,825) (6,673)
Cash Flows From Investing Activities    
Purchase of property and equipment (48) (913)
Sale of property and equipment 39
Net cash used in investing activities (9) (913)
Cash Flows From Financing Activities    
Issuance of common stock, net of expenses 108 434
Issuance of Series B preferred stock, net of expenses 19,537
Loan proceeds - related parties 7,500
Deferred financing fees (105)
Borrowings on Line of Credit 400
Net cash provided by financing activities 7,503 20,371
Net increase in cash, cash equivalents and restricted cash 669 12,785
Cash, cash equivalents and restricted cash – beginning 3,372 2,321
Cash, cash equivalents and restricted cash – ending $ 4,041 $ 15,106